iBio, Inc.
IBIO
$4.52
-$0.34-7.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 46.85% | 30.58% | -28.92% | 56.51% | 75.53% |
| Total Depreciation and Amortization | -11.08% | -12.03% | -5.25% | 17.50% | 8.22% |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | -100.00% | -63.86% |
| Total Other Non-Cash Items | -85.94% | -43.02% | 611.81% | -179.86% | -83.75% |
| Change in Net Operating Assets | -105.83% | 42.45% | -22,380.00% | -104.73% | -102.24% |
| Cash from Operations | 17.79% | 30.43% | 2.33% | 5.63% | 38.36% |
| Capital Expenditure | -- | -- | 58.50% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -86.80% | -100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -83.16% | -- |
| Cash from Investing | -- | 1,326.00% | -2,300.00% | -87.87% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -58.88% | 69.26% | -38.28% | 93.80% | 98.31% |
| Issuance of Common Stock | -99.56% | -99.87% | 291.42% | 11.47% | 43.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | 82.05% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -103.80% | -106.55% | 374.16% | 243.24% | 231.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -473.89% | -12.28% | 462.87% | -59.35% | 94.13% |
